GoodRx Inc. orchestrated a pricing scheme that benefited it and other big pharmacy benefit managers at the expense of independent pharmacies, a proposed class action filed in federal court says.
The PBMs named in the suit as co-conspirators with GoodRx are
PBM’s are third party ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
